Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics versus laparoscopic appendicectomy for uncomplicated acute appendicitis
ACTRN12620000537954Phase 3Recruiting
- Sponsor
- The University of Queensland
- Start
- Mar 2020
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of piperacillin + tazobactam, ceftriaxone, metronidazole, amoxicillin + ampicillin, gentamicin and 2 more in appendicitis (2 arms), sponsored by The University of Queensland. Primary endpoint: Primary outcome: treatment success. Started Mar 2020; status: recruiting.
02
Drugs
piperacillin + tazobactamceftriaxonemetronidazoleamoxicillin + ampicillingentamicin
03
Conditions
appendicitis
Beyond the preview
Go deeper on ACTRN12620000537954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000537954.